Genpact chief accounting officer sells $226,942 in stock

Donald J. Klunk, the Chief Accounting Officer of Genpact LTD (NYSE:G), recently sold a portion of his holdings in the company. According to a recent SEC filing, Klunk sold 4,136 common shares at a weighted average price of $54.87, resulting in a total transaction value of approximately $226,942. The sale comes as Genpact’s stock trades near its 52-week high, having delivered an impressive 59% return over the past year. InvestingPro analysis indicates the stock is currently in overbought territory, though the company maintains a GREAT financial health score. Following this sale, Klunk retains ownership of 8,777 shares in the company. The sale was executed on February 11, 2025, with the prices for the shares ranging from $54.86 to $54.88. While management has been actively buying back shares, InvestingPro subscribers can access 15+ additional exclusive insights and detailed insider trading patterns to make more informed investment decisions.

In other recent news, Genpact Ltd . has been the focus of several positive analyst updates, following strong fourth-quarter results and optimistic 2025 guidance that exceeded expectations. Mizuho (NYSE:MFG) Securities raised Genpact’s stock price target to $55, citing robust revenue growth, effective strategy implementation, and progress in GenAI. BMO Capital Markets also increased the price target to $58, applauding the company’s consistent performance and potential for further upside, despite expressing reservations about the long-term sustainability of growth.

TD Cowen upgraded Genpact from ’Hold’ to ’Buy’ and increased the price target to $60, following an earnings report that surpassed consensus expectations. The company’s guidance for 2025 also outperformed the consensus, with an anticipated EPS of $3.52-$3.59 and revenue forecasts ranging from $5.029 to $5.125 billion.

Needham maintained a Buy rating on Genpact, raising the price target to $65. The firm praised Genpact’s impressive execution, strong bookings momentum, and shareholder-friendly capital deployment strategy. BofA Securities also raised the price target to $58, maintaining a Buy rating. The firm highlighted Genpact’s performance, particularly in the Data-Tech-AI segment, and the company’s improved guidance for 2025.

These are the latest developments for Genpact, reflecting a positive outlook from analysts and promising financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.